Correlation Between Cingulate Warrants and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Cingulate Warrants and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Cadrenal Therapeutics,.
Diversification Opportunities for Cingulate Warrants and Cadrenal Therapeutics,
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and Cadrenal is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Cadrenal Therapeutics,
Assuming the 90 days horizon Cingulate Warrants is expected to under-perform the Cadrenal Therapeutics,. In addition to that, Cingulate Warrants is 4.06 times more volatile than Cadrenal Therapeutics, Common. It trades about -0.08 of its total potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about 0.13 per unit of volatility. If you would invest 1,740 in Cadrenal Therapeutics, Common on November 18, 2024 and sell it today you would earn a total of 168.00 from holding Cadrenal Therapeutics, Common or generate 9.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cingulate Warrants vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Cingulate Warrants |
| Cadrenal Therapeutics, |
Cingulate Warrants and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Cadrenal Therapeutics,
The main advantage of trading using opposite Cingulate Warrants and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd | Cingulate Warrants vs. Dermata Therapeutics Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |